Neurologic outcomes of toxic oil syndrome patients 18 years after the epidemic

Environmental Health Perspectives

Volumn 111, Issue 10, 2003, Pages 1326-1334

  Posada de la Paz, Manuel ^a   Philen, Rossanne M ^b   Gerr, Fredric ^c   Letz, Richard ^d   Ferrari Arroyo, Maria José ^a   Vela, Lydia ^e   Izquierdo, Maravillas ^a   Arribas, Concepción Martín ^a   Abaitua Borda, Ignacio ^a   Ramos, Alejandro ^a   Mora, Cristina ^a   Matesanz, Gloria ^a   Roldán, Maria Teresa ^a   Pareja, Juan ^e  

^a CENTRO DE INVESTIGACIONES BIOLÓGICAS   (Spain)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c UNIVERSITY OF IOWA   (United States)

^d EMORY UNIVERSITY   (United States)

^e HOSPITAL UNIVERSITARIO FUNDACIÓN ALCORCÓN   (Spain)

Author keywords

Case referent study; Environmental food epidemic; Exam; Long term effects; Neurobehavioral tests; Toxic oil syndrome

Indexed keywords

ANILINE; RAPESEED OIL;

ADULT; ARTICLE; CLINICAL EXAMINATION; COGNITION; COMPUTER; CONTROLLED STUDY; DEMOGRAPHY; DENATURATION; EDUCATION; EPIDEMIC; EXPOSURE; FEMALE; FOLLOW UP; FOOD INTAKE; HEALTH STATUS; HEMISPHERIC DOMINANCE; HUMAN; INTELLIGENCE TEST; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; NEUROLOGIC DISEASE; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TEST; NURSE; PERCEPTIVE THRESHOLD; PRIORITY JOURNAL; PSYCHOPATHY; QUESTIONNAIRE; RESPONSE TIME; STATISTICAL SIGNIFICANCE; TOUCH; TOXIC OIL SYNDROME; VISUAL THRESHOLD;

SINAPIS ARVENSIS; TOSCANA VIRUS;

EID: 0042975396     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.6098     Document Type: Article

References (33)

1. Abaitua I, Philen R, Posada M, Gómez de la Cámara A, Diez M, Giménez O, et al. 1998, Toxic oil syndrome mortality: the first 13 years. Int J Epidemiol 27:1057-1063.
2. Abaitua Borda I, Posada de la Paz M. 1991, Clinical findings. In: Toxic Oil Syndrome: Current Knowledge and Future Perspectives (World Health Organization, ed). WHO Regional Publications, European Series, No. 42. Copenhagen:World Health Organization, 23-34.
3. Baker EL, Letz RE, Eisen EA, Pothier LJ, Plantamura DL, Larson M, et al. 1988. Neurobehavioral effects of solvents in construction painters. J Occup Med 30(2):116-123.
4. Baker EL, Letz R, Fidler A. 1985. A computer-administered neurobehavioral evaluation system for occupational and environmental epidemiology. Rationale, methodology, and pilot study results. J Occup Med 27(3):206-212.
5. Cuba Neuropathy Field Investigation Team. 1995. Epidemic optic neuropathy in Cuba: clinical characterization and risk factors. N Engl J Med 333:1176-1182.
6. Gelpi E, Posada de la Paz M, Terracini B, Abaitua I, Gomez de la Camara A, Kilbourne EM, et al. 2002. The Spanish toxic oil syndrome 20 years after its occurrence: a multidisciplinary review of scientific knowledge. Environ Health Perspect 110:457-464.
7. Gerr F, Hershman D, Letz R. 1990. Vibrotactile threshold measurement for detecting neurotoxicity: reliability and determination of age- and height-standardized normative values. Arch Environ Health 45(3):148-154.
8. Gerr FE, Letz R. 1988. Reliability of a widely used test of peripheral cutaneous vibration sensitivity and a comparison of two testing protocols. Br J Ind Med 45(9):635-639.
9. Gerr FE, Letz R. 1993. Vibrotactile threshold testing in occupational health: a review of current issues and limitations. Environ Res 60(1)145-159.
10. Gerr F, Letz R, Hershman D, Farraye J, Simpson D. 1991. Comparison of vibrotactile thresholds with physical examination and electrophysiological assessment. Muscle Nerve 14:1059-1066
11. Gomez A, Posada M, Abaitua I, Barainca MT, Abraira V, Diez M, et al. 1998. Health status measurement in toxic oil syndrome. J Clin Epidemiol 51:867-873.
12. Kaufman AS, Kaufman NL. 1996. Kaufman Brief Intelligence Test [Spanish ed]. Madrid:TEA Ediciones, S.A. Fray Bernardino do Sahagún.
13. Kilbourne EM. 1992. Eosinophilia-myalgia syndrome: coming to grips with a new illness. Epidemiol Rev 14:16-36.
14. Kilbourne EM, Posada de la Paz M, Abaitua Borda I. 1992. Epidemiological studies. WHO Reg Publ Eur Ser (42):5-25.
15. Letz R. 1991. Use of computerized test batteries for quantifying neurobehavioral outcomes. Environ Health Perspect 90:195-198.
16. Letz R, Gerr F. 1995. Standing steadiness measurements: empirical selection of testing protocol and outcome measures. Neurotoxicol Teratol 17(6):611-616.
17. Letz R, Green RC, Woodard JL. 1996. Development of a computer-based battery designed to screen adults for neuropsychological impairment. Neurotoxicol Teratol 18(4):365-370.
18. Martín Alvarez H, Plaza Cano M, Estirado de Cabo E, Garcia de Aguinaga M, Izquierdo Martínez M, Posada de la Paz M. 2000. Hallazgos clínicos y analíticos en pacietnes afectados por el síndrome del aceite tóxico [in Spanish]. Estudio de una cohorto de 758 pacientes. Rev Clin Esp 200(6):305-309.
19. Mathiowetz V, Weber K, Volland G, Kashman N. 1984. Reliability and validity of grip and pinch strength evaluation. J Hand Surg 9(2):222-622.
20. Montón C, Pérez M, Campos R, Garcia J, Lobo A. 1993. Escalas de ansiedad y depression de Goldberg: un guía de entrevista eficaz para la detección del malestar psíquico [in Spanish]. Atención Primaria 12:345-349.
21. Murata K, Araki S. 1991. Autonomic nervous system dysfunction in workers exposed to lead, zinc, and copper in relation toperipheral nerve conduction: a study of R-R variability. Am J Ind Med 20:663-671.
22. Peña-Casanova J. 1990. Programa Integrado de Exploración Neuropsicológica (PIEN Test Barcelona) [in Spanish]. Barcelona:Masson.
23. Philen R.M., Posada M. 1993. Toxic oil syndrome and eosinophilia myalgia syndrome. WHO meeting report. Semin Arthritis Rheum 23:104-124.
24. Portera-Sanchez A, Posada de la Paz M. 2000. Toxic oil. In: Experimental and Clinical Neurotoxicology (Spencer PS, Schaumburg HH, eds). New York:Oxford University Press, 1193-1196.
25. Posada de la Paz M, Abaitua I, Terracini B, Giménez O, Sánchez-Porro P, Gómez-Mera C. 1999. Late deaths among young women affected by the toxic oil syndrome in Spain [Letter]. Epidemiology 10(3):345.
26. Posada de la Paz M, Philen RM, Abaitua Borda I. 2001. Toxic oil syndrome: the perspective after twenty years. Epidemiol Rev 23(2):231-247.
27. Ricoy JR, Cabello A, Rodriguez J, Tellez I. Neuropathological studies on the toxic syndrome related to adulterated rapeseed oil in Spain. 1983. Brain 106(4):817-835.
28. SAS Institute. 1989. SAS/STAT User's Guide, Version 6.12. Vol 2. 4th ed. Cary, NC:SAS Institute, Inc.
29. Stokes L, Letz R, Gerr F, Kolczak M, McNeill FE, Chettle DR, et al. 1998. Neurotoxicity in young adults 20 years after childhood exposure to lead: the Bunker Hill experience. Occup Environ Med. 55(8):507-516.
30. Sullivan EA, Kamb ML, Jones JL, Meyer P, Philen RM, Falk H, et al. 1996. The natural history of eosinophilia-myalgia syndrome in a tryptophan-exposed cohort in South Carolina. Arch Internal Med 156:973-979.
31. Tabuenca JM. 1981. Toxic allergic syndrome caused by ingestion of rapeseed oil denatured with aniline. Lancet 2:567-568.
32. Tyler KL. 2003. Creutzfeldt-Jakob Disease. N Engl J Med 348:681-682.
33. Van Larebeke N, Hens L, Schepens P, Covaci A, Baeyens J, Everaert K, et al. 2001. The Belgian PCB and dioxin incident of January-June 1999: exposure data and potential impact on health. Environ Health Perspect 109:265-273.